Search results
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 21 hours agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 18 hours agoNormally, investors wouldn't reward such declines and steep shortfalls. But the market was braced for a notably worse showing. On average, analysts...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 24 hours agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 5 hours agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 21 hours agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 1 day agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 1 day agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 1 day agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Zacks via Yahoo Finance· 7 days agoModerna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 23 hours agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
